Nabriva Therapeutics
NBRV
$1.42
Share price
0.00%
Change (1 day)
-71.20%
Change (1 year)
Categories
P/S ratio for Nabriva Therapeutics (NBRV)
P/S ratio as of May 2024 (TTM): 0.1275
According to Nabriva Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.127455. At the end of 2023 the company had a P/S ratio of 0.1504.
P/S ratio history for Nabriva Therapeutics from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.1504 | -7.37% |
| 2022 | 0.1624 | -86.99% |
| 2021 | 1.25 | -92.99% |
| 2020 | 17.8 | 10.58% |
| 2019 | 16.1 | 7% |
| 2018 | 15.1 | |
| 2017 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |